Dr. Reddy’s Laboratories is a global pharmaceutical company providing affordable medicines across various therapeutic areas.

Dr. Reddy’s Laboratories (BSE:500124), (NSE:DRREDDY), (NYSE:RDY), (NSEIFSC:DREDDY) operates as a global pharmaceutical company dedicated to providing affordable and innovative medicines across various therapeutic areas, including cardiovascular, oncology, gastroenterology, and dermatology, among others. It focuses on research and development, manufacturing, and marketing a wide range of medications. With operations in major markets around the world, Dr. Reddy’s aims to accelerate access to high-quality medicines for patients through its expansive product portfolio and numerous collaborative projects within the pharmaceutical industry. The company's objectives revolve around enhancing healthcare outcomes globally, leveraging scientific research to launch novel therapies, and expanding its presence in key markets to meet the growing demands of healthcare providers and patients alike.